Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

The selection of appropriate outcome measures is fundamental to the design of any successful clinical trial. Although dementia with Lewy bodies (DLB) is one of the most common neurodegenerative conditions, assessment of therapeutic benefit in clinical trials often relies on tools developed for other...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez-Porcel, Federico, Wyman-Chick, Kathryn A., Abdelnour Ruiz, Carla, Toledo, Jon B., Ferreira, Daniel, Urwyler, Prabitha, Weil, Rimona S., Kane, Joseph, Pilotto, Andrea, Rongve, Arvid, Boeve, Bradley, Taylor, John-Paul, McKeith, Ian, Aarsland, Dag, Lewis, Simon J. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059356/
https://www.ncbi.nlm.nih.gov/pubmed/35491418
http://dx.doi.org/10.1186/s40035-022-00299-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059356/
https://www.ncbi.nlm.nih.gov/pubmed/35491418
http://dx.doi.org/10.1186/s40035-022-00299-w

Ejemplares similares